Moderna (MRNA) calls active into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study

Moderna (NASDAQ: MRNA) 30 option implied volatility is at 87; compared to its 52-week range of 51 to 99 into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study. Call put ratio 6 calls to 1 put.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Sandisk (SNDK) call put ratio 1 call to 1.2 puts a focus on June 26 weekly 1290 puts into Korean market weakness and Micron (MU) quarter results
• Dataram (DRAM) call put ratio 1.4 calls to 1 put into Korean market weakness and Micron (MU) quarter results